← FDA Drug Approvals (Drugs@FDA)
ETYQA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-06-30
Drug application
- FDA Application #
ANDA214729
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ETYQA
- Generic name
- ESTRADIOL AND NORETHINDRONE ACETATE
- Active ingredients
- ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2023-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown